Discovery MI Gen 2 is engineered to deliver

  1. Optional works in progress. 30 cm AFOV configuration not for sale. Not approved by the U.S. FDA or any other global regulator for commercial availability. 
  2. As demonstrated in a clinical evaluation consisting of 60 cases and 7 physicians, where each case was reconstructed with both DLIR and ASiR-V™ and evaluated by 3 of the physicians. In 90% of the reads, DLIR’s noise texture was rated better than ASiR-V’s. In 99% of the reads, DLIR’s image sharpness was rated the same as or better than ASiR-V’s.
  3. Discovery MI Gen 2 has the highest NEMA sensitivity in the market, comparing with common PET/CT systems with same or similar AFOV, (based on IMV’s Medical Information Division’s 2019 report as the manufacturers representing more than 90% of the US Installed Base).
  4. As demonstrated in phantom testing using a typical and fast respiratory model and OSEM reconstruction. Quantitative accuracy improvements are based on SUVmean. 
  5. Compared to non-processed (STATIC, no motion-correction) data. As demonstrated in phantom testing using a typical and fast respiratory model, 18 mm Ge-68 spheres and OSEM reconstruction.
  6. Based on clinical practice at University Hospital Zurich, using 5-Ring PET/CT with MotionFree and RPM. These results are for illustrative purposes only and represent specific customer experiences; actual results could vary depending on clinical practice and circumstances.